CompletedPhase 1ketamine

The Effect of Low Dose Intra-operative Ketamine on Closed-loop Controlled General Anesthesia

Sponsored by NeuroWave Systems Inc.

NCT ID
NCT03009409
Target Enrollment
60 participants
Start Date
2018-03-13
Est. Completion
2018-10-17

About This Study

Closed-loop control of anesthesia involves using feedback from a measure of clinical effect to continuously adjust drug infusion rates. As a result, anesthetic drugs are delivered at a variable rate that is frequently personalized to each individual patient. The aim is to provide greater stability at an optimal depth of anesthesia, reducing the occurrence of under- or overdosing, with the goal of ultimately improving patient outcomes. The purpose of this randomized, controlled equivalence trial is to compare controller performance during closed-loop controlled induction and maintenance of total intravenous anesthesia, using iControl system, with the addition of a low (analgesic) dose of ketamine versus saline control.

Conditions Studied

Anesthesia

Interventions

  • Ketamine Injectable Solution
  • Placebo

Eligibility

Age:19 Years - 54 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age 19-54
* ASA I-II
* BMI 15-45
* Elective ACL repair surgery requiring general anesthesia
* Ability to read and understand the informed consent form

Exclusion Criteria:

* Contraindications to ketamine use Those in whom a significant elevation of blood pressure would constitute a serious hazard (e.g. severe cardiovascular disease, pacemaker, pheochromocytoma, malignant hypertension, intraocular pressure pathology, acute globe injury, hyperthyroidism)
* Contraindications to propofol Anaphylactic reaction to eggs, egg products, soybeans or soy products
* Contraindications to remifentanil Hypersensitivity to fentanyl analogues
* Known or suspected neurological disease Tumor, stroke, neurodegenerative disease, major head injury, seizure disorder Abnormality in any previous EEG examination Cognitive deficits (e.g. dementia, developmental delay)
* Acquired scalp or skull abnormalities
* Psychiatric illness Severe depression, PTSD, psychosis Any psychotropic medication taken in the past 7 days
* History of drug misuse/abuse within past 30 days Ketamine, cocaine, heroin, amphetamines, phencyclindine, lysergic acid (LSD), mescaline, psilocybin Chronic alcoholism
* Requirement for pre-operative sedative medication (e.g. midazolam) for anxiolysis
* Anticipated intra-operative or pre-operative use of nitrous oxide, catecholamines (dopamine, epinephrine, norepinephrine) or thyroid hormones
* Pregnant or nursing
* Currently enrolled in any other research study involving drugs or devices

Study Locations (1)

Fraser Health: Eagle Ridge Hospital
Port Moody, British Columbia, Canada

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source